US Stock MarketDetailed Quotes
IRD Opus Genetics
- 1.170
- +0.040+3.54%
Close Oct 25 16:00 ET
- 1.200
- +0.030+2.56%
Post 19:40 ET
36.78MMarket Cap-2166P/E (TTM)
1.200High1.140Low205.83KVolume1.200Open1.130Pre Close240.23KTurnover0.69%Turnover RatioLossP/E (Static)31.44MShares3.39952wk High0.90P/B34.82MFloat Cap1.07252wk Low--Dividend TTM29.76MShs Float13.812Historical High--Div YieldTTM5.31%Amplitude1.072Historical Low1.167Avg Price1Lot Size
Opus Genetics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -837.31%-7.29M | -56.77%-5.72M | -107.77%-1.11M | -84.20%4.55M | 33.24%-3M | 125.96%989K | 40.91%-3.65M | 173.90%14.31M | 609.94%28.79M | -25.50%-4.5M |
| Net income from continuing operations | -56.52%-7.77M | -22.71%-7.11M | -155.83%-9.99M | -114.13%-4.8M | 222.73%5.56M | -0.69%-4.96M | 12.19%-5.79M | 131.55%17.89M | 637.64%33.94M | -7.12%-4.53M |
| Operating gains losses | ---- | ---- | ---80K | ---19K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | --0 | --0 | 50.00%6K | 200.00%3K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%4K | 0.00%1K | 0.00%1K |
| Other non cash items | ---- | ---- | --1.33M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -107.36%-333K | -69.92%395K | 173.38%4.08M | 253.76%8.65M | -2,043.21%-10.42M | 582.81%4.53M | 1,350.48%1.31M | -3,169.06%-5.56M | -24,565.22%-5.63M | -188.36%-486K |
| -Change in receivables | -68.42%812K | -74.06%-785K | 151.90%2.52M | 285.77%9.01M | ---8.61M | --2.57M | ---451K | ---4.85M | ---4.85M | --0 |
| -Change in prepaid assets | 25.28%446K | -226.30%-461K | 354.68%354K | 27.48%-615K | 83.70%248K | 0.28%356K | 66.67%365K | -208.89%-139K | -12.47%-848K | -65.91%135K |
| -Change in payables and accrued expense | -199.44%-1.59M | 17.30%1.64M | 312.90%1.21M | 261.97%257K | -230.27%-2.05M | 419.48%1.6M | 531.79%1.4M | -350.44%-566K | -90.86%71K | -697.12%-621K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -837.31%-7.29M | -56.77%-5.72M | -107.77%-1.11M | -84.20%4.55M | 33.24%-3M | 125.96%989K | 40.91%-3.65M | 173.90%14.31M | 609.94%28.79M | -25.50%-4.5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | ||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.54M | 2.38M | 137.16%8.98M | 30,125.00%3.6M | 304.82%5.38M | 0 | 0 | -86.29%3.79M | -100.15%-12K | -17.00%1.33M |
| Net issuance payments of debt | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -200.00%-538K | --0 | --0 |
| Net common stock issuance | --1.56M | --2.44M | 108.38%9.23M | --3.75M | 302.50%5.48M | --0 | --0 | -84.46%4.43M | --0 | -21.68%1.36M |
| Proceeds from stock option exercised by employees | ---- | ---- | 11.11%30K | --30K | ---- | ---- | ---- | -68.97%27K | --0 | --0 |
| Net other financing activities | ---22K | ---61K | -112.21%-278K | -1,333.33%-172K | ---- | ---- | ---- | 91.33%-131K | 93.81%-12K | 84.19%-34K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --1.54M | --2.38M | 137.16%8.98M | 30,125.00%3.6M | 304.82%5.38M | --0 | --0 | -86.29%3.79M | -100.15%-12K | -17.00%1.33M |
| Net cash flow | ||||||||||
| Beginning cash position | 20.96%47.16M | 18.45%50.5M | 73.78%42.63M | 205.67%42.35M | 134.81%39.98M | 102.58%38.99M | 73.78%42.63M | 49.61%24.53M | -37.73%13.86M | -29.75%17.03M |
| Current changes in cash | -681.60%-5.75M | 8.39%-3.34M | -56.54%7.87M | -71.68%8.15M | 174.86%2.37M | 144.53%989K | 31.05%-3.65M | 122.50%18.1M | 1,160.03%28.78M | -59.78%-3.17M |
| End cash Position | 3.58%41.41M | 20.96%47.16M | 18.45%50.5M | 18.45%50.5M | 205.67%42.35M | 134.81%39.98M | 102.58%38.99M | 73.78%42.63M | 73.78%42.63M | -37.73%13.86M |
| Free cash flow | -837.31%-7.29M | -56.77%-5.72M | -107.77%-1.11M | -84.20%4.55M | 33.24%-3M | 125.96%989K | 40.91%-3.65M | 173.90%14.31M | 609.94%28.79M | -25.50%-4.5M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data